Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Retinitis Pigmentosa May Be Treated by Reprogramming Sugar Metabolism

Manipulating retinal sugar use prolonged survival of cones and rods in preclinical model of retinitis pigmentosa
November 14, 2016
Genetics Retinitis Pigmentosa
Translational Research
Grantee

NEI-funded researchers at Columbia University Medical Center have shown that vision loss associated with a form of retinitis pigmentosa can be slowed dramatically by reprogramming the metabolism of photoreceptors, or light sensors, in the retina. The study, conducted in mice, and published in the Journal of Clinical Investigation, represents a new treatment approach.